References

Acne No More Ebook

New Home Remedy to Cure Acne

Get Instant Access

1. Cunliffe WJ. Acne. London: Martin Dunitz Ltd, 1989.

2. Newton JN, Edwards C. Epidemiology and treatment of acne in primary care. J Eur Acad Dermatol Venereol 1997: 9(suppl.1):581.

3. Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: Results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001:15:541-5.

4. Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J. Acne vulgaris in premenarchal girls: An early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol 1994;130:308-14.

5. Lucky AW, Biro FM, Simbarti LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: Results of a five-year longitudinal study. J Pediatr 1997;130:30-9.

6. Stewart ME, Downing DT, Cook JS, Hansen JR, Strauss JS. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol 1992;128:1345-8.

7. Burton JL, Cunliffe WJ, Stafford I, Shuster S. The prevalence of acne vulgaris in adolescence. Br J Dermatol 1971;85:119-26.

8. Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. BMJ 1979;1:1109-10.

9. Siemens HW. [The treatment and control of patients with acne]. [German]. Munchener Medizinische Wochenschrift 1965;107:1652-5.

10. Walton S, Wyatt R, Cunliffe WJ. Genetic control of sebum excretion and acne. A twin study. Br J Dermatol 1988;18:393-6.

11. Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999;141:297-300.

12. Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997;136: 66-70.

13. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986; 115:386.

14. Lehmann HP, Andrews JS, Robinson KA et al. Management of Acne (Evidence Report/Technology Assessment No. 17 (Prepared by Johns Hopkins Evidence-based Practice Center under Contract No. 290-97-006). AHRQ Publication No. 01-E019. Rockville, MD: Agency for Healthcare Research and Quality, September 2001.

15. Bettley FR, Dale TL. The local treatment of acne. Br J Clin Pract 1976;30:67-9.

16. Korting HC, Ponce-Poschl E, Klovekorn W, Schmotzer G, Arens-Corell M, Braun-Falco O. The influence of the regular use of a soap or an acidic syndet bar on pre-acne. Infection 1995;23:89-93.

17. Milikan LE. A double-blind study of Betadine skin cleanser in acne vulgaris. Cutis 1976;17:394-8.

18. Fulghum DD, Catalano PM, Childers RC, Cullen SI, Engel MF. Abrasive cleansing in the management of acne vulgaris. Arch Dermatol 1982;118:658-9.

19. Kanof NB. Acne control with an antibacterial soap bar - a double-blind study. Cutis 1971;7:57-61.

20. Stoughton RB, Leyden JJ. Efficacy of 4 percent chlorhexidine gluconate skin cleanser in the treatment of acne vulgaris. Cutis 1987;39:551-3.

21. Millikan LE, Ameln R. Use of Buf-Puf(TM) and benzoyl peroxide in the treatment of acne. Cutis 1981;28:201-5.

22. Vaughan Jones SA, Hern S, Black MM. Neutrophil folliculitis and serum androgen levels. Clin Exp Dermatol 1999;24:392-5.

23. Korting HC, Kober M, Mueller M, Braun-Falco O. Influence of repeated washings with soap and synthetic detergents on pH and resident flora of the skin of forehead and forearm. Acta Derm Venereol 1987;67:41-7.

24. Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0-1% gel versus tretinoin 0-025% gel in patients with acne vulgaris: A meta-analysis of five randomized trials. Br J Dermatol 1998;139(Suppl. 52):48-56.

25. Caron D, Sorba V, Kerrouche N, Clucas A. Split-face comparison of adapalene 0-1% gel and tretinoin 0-025% gel in acne patients. J Am Acad Dermatol 1997;36(6 II Suppl):S110-S112.

26. Dunlap FE, Mills OH, Tuley MR, Baker MD, Plott RT. Adapalene 0-1% gel for the treatment of acne vulgaris: Its superiority compared to tretinoin 0-025% cream in skin tolerance and patient preference. Br J Dermatol 1998: 139(Suppl. 52):17-22.

27. Galvin SA, Gilbert R, Baker M, Guibal F, Tuley MR. Comparative tolerance of adapalene 0-1% gel and six different tretinoin formulations. Br J Dermatol 1998; 139(Suppl. 52):34-40.

28. Verschoore M, Langner A, Wolska H, Jablonska S, Czernielewski J, Schaefer H. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris. Br J Dermatol 1991;124:368-71.

29. Alirezai M, Meynadier J, Jablonska S, Czernielewski J, Verschoore M. [Comparative study of the efficacy and tolerability of 0-1 and 0-03 p.100 adapalene gel and 0-025

p.100 tretinoin gel in the treatment of acne]. [French]. Ann Dermatol Venereol 1996;123:165-70.

30. Grosshans E, Marks R, Mascaro JM et al. Evaluation of clinical efficacy and safety of adapalene 0-1% gel versus tretinoin 0-025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998;139(Suppl 52):26-33.

31. Berger RS, Griffin E, Jones L et al. Clinical safety and efficacy evaluation of 0-1% CD271 gel versus 0-025% Retin A gel and CD271 gel vehicle. 2002. Unpublished data (CIRD Galderma).

32. Clucas A, Verschoore M, Sorba V, Poncet M, Baker M, Czernielewski J. Adapalene 0-1% gel is better tolerated than tretinoin 0-025% gel in acne patients. J Am Acad Dermatol 1997;36(6 Pt 2):S116-18.

33. Ellis CN, Millikan LE, Smith EB et al. Comparison of adapalene 0-1% solution and tretinoin 0-025% gel in the topical treatment of acne vulgaris. Br J Dermatol 1998;139(Suppl. 35):41-7.

34. Shalita A, Weiss JS, Chalker DK et al. A comparison of the efficacy and safety of adapalene gel 0-1% and tretinoin gel 0-025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996;34:482-5.

35. Christiansen JV, Gadborg E, Ludvigsen K et al. Topical vitamin A acid (Airol) and systemic oxytetracycline in the treatment of acne vulgaris. A controlled clinical trial. Dermatologica 1974;149:121-8.

36. Krishnan G. Comparison of two concentrations of tretinoin solution in the topical treatment of acne vulgaris. Practitioner 1976;216:106-9.

37. Schafer-Korting M, Korting HC, Ponce-Poschl E. Liposomal tretinoin for uncomplicated acne vulgaris. Clin Invest 1994;72:1086-91.

38. Dominguez J, Hojyo MT, Celayo JL, Dominguez-Soto L, Teixeira F. Topical isotretinoin v. topical retinoic acid in the treatment of acne vulgaris. Int J Dermatol 1998;37:54-5.

39. Elbaum DJ. Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne. J Am Acad Dermatol 1988; 19(3):486-91.

40. Christiansen J, Holm P, Reymann F. Treatment of acne vulgaris with the retinoic acid derivative Ro 11-1430. A controlled clinical trial against retinoic acid. Dermatologica 1976;153:172-6.

41. Christiansen J, Holm P, Reymann F. The retinoic acid derivative Ro 11-1430 in Acne vulgaris. A controlled multicenter trial against retinoic acid. Dermatologica 1977;154:219-27.

42. Hughes BR, Norris JF, Cunliffe WJ. A double-blind evaluation of topical isotretinoin 0-05%, benzoyl peroxide gel 5% and placebo in patients with acne. Clin Exp Dermatol 1992;17:165-8.

43. Nordin K, Fredriksson T, Rylander C. Ro 11-1430, a new retinoic acid derivative for the topical treatment of acne. Dermatologica 1981;162:104-11.

44. Shalita AR, Chalker DK, Griffith RF et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study. Cutis 1999;63:349-54.

45. Pierard-Franchimont C, Henry F, Fraiture AL, Fumal I, Pierard GE. Split-face clinical and bio-instrumental comparison of 0-1% adapalene and 0-05% tretinoin in facial acne. Dermatology 1999;198:218-22.

46. Cunliffe WJ, Caputo R, Dreno B et al. Efficacy and safety comparison of adapalene (CD271) gel and tretinoin gel in the topical treatment of acne vulgaris. A European multicentre trial. J Dermatol Treat 1997;8:173-8.

47. Dunlap FE, Baker MD, Plott RT, Verschoore M. Adapalene 0-1% gel has low skin irritation potential even when applied immediately after washing. Br J Dermatol 1998;139(Suppl. 35):23-5.

48. Handojo I. The combined use of topical benzoyl peroxide and tretinoin in the treatment of acne vulgaris. Int J Dermatol 1979;18:489-96.

49. Lyons RE. Comparative effectiveness of benzoyl peroxide and tretinoin in acne vulgaris. Int J Dermatol 1978;17:246-51.

50. Bucknall JH, Murdoch PN. Comparison of tretinoin solution and benzoyl peroxide lotion in the treatment of acne vulgaris. Curr Med Res Opin 1977;5:266-8.

51. Christiansen JV, Gadborg E, Ludvigsen K et al. Topical tretinoin, vitamin A acid (Airol) in acne vulgaris. A controlled clinical trial. Dermatologica 1974;148:82-9.

52. Van Hoogdalem EJ, Baven TL, Spiegel-Melsen I, Terpstra IJ. Transdermal absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man. Biopharmaceutics Drug Disposition 1998;19:563-9.

53. Mills OH, Jr., Kligman AM, Pochi P, Comite H. Comparing 2-5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol 1986;25:664-7.

54. Smith EB, Padilla RS, McCabe JM, Becker LE. Benzoyl peroxide lotion (20%) in acne. Cutis 1980;25:90-2.

55. Hunt MJ, Barnetson RS. A comparative study of gluconolactone versus benzoyl peroxide in the treatment of acne. Australasian J Dermatology 1992;33:131-4.

56. Jaffe GV, Grimshaw JJ, Constad D. Benzoyl peroxide in the treatment of acne vulgaris: a double-blind, multi-centre comparative study of "Quinoderm" cream and "Quinoderm" cream with hydrocortisone versus their base vehicle alone and a benzoyl peroxide only gel preparation. Curr Med Res Opin 1989;11:453-62.

57. Ede M. A double-blind, comparative study of benzoyl peroxide, benzoyl peroxide-chlorhydroxyquinoline, benzoyl peroxide-chlorhydroxyquinoline-hydrocortisone, and placebo lotions in acne. Curr Ther Res Clin Exp 1973;15:624-9.

58. Lookingbill DP, Chalker DK, Lindholm JS et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: Combined results of two double-blind investigations. J Am Acad Dermatol 1997;37:590-5.

59. Yong CC. Benzoyl peroxide gel therapy in acne in Singapore. Int J Dermatol 1979;18:485-8.

60. Handojo I. Retinoic acid cream (Airol cream) and benzoyl-peroxide in the treatment of acne vulgaris. Southeast Asian J Trop Med Public Health 1979;10:548-51.

61. Cavicchini S, Caputo R. Long-term treatment of acne with 20% azelaic acid cream. Acta Derm Venereol Suppl 1989;143:40-4.

62. Cartwright RA, Hughes BR, Cunliffe WJ. Malignant melanoma, benzoyl peroxide and acne: a pilot epidemiological case-control investigation. Br J Dermatol 1988;118:239-42.

63. Liden S, lindelof B, Sparen P. Is benzoyl peroxide carcinogenic. Br J Dermatol 1990; 123:129.

64. Kraus AL, Munro IC, Orr JC, Binder RL, LeBoeuf RA, Williams GM. Benzoyl peroxide: An integrated human safety assessment for carcinogenicity. Regul Toxicol Pharmacol 1995;21:87-107.

65. Eady EA, Jones CE, Tipper JL et al. Antibiotic resistant propionibacteria in acne; need for policies to modify antibiotic usage. BMJ 1993;306:555-6.

66. Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant Propionibacteria. Br J Dermatol 1996;134:107-13.

67. Shalita AR. Treatment of mild and moderate acne vulgaris with salicylic acid in an alcohol-detergent vehicle. Cutis 1981;28:556-8.

68. Roth HL. Acne vulgaris: evaluation of a medicated cleansing pad. Calif Med 1964;100:167.

69. Gibson JR. Azelaic acid 20% cream (AZELEX) and the medical management of acne vulgaris. [Review] [30 refs]. Dermatol Nurs 1997;9(5):339-44.

70. Kurokawa I, Akamatsu H, Nishijima S, Asada Y, Kawabata S. Clinical and bacteriologic evaluation of OPC-7251 in patients with acne: a double-blind group comparison study versus cream base. J Am Acad Dermatol 1991;25:674-81.

71. Cunliffe WJ, Holland KT. Clinical and laboratory studies on treatment with 20% azelaic acid cream for acne. Acta Derm Venereol Suppl 1989;143:31-4.

72. Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin. Acta Derm Venereol Suppl 1989;143:35-9.

73. Bladon PT, Burke BM, Cunliffe WJ, Forster RA, Holland KT, King K. Topical azelaic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracycline. Br J Dermatol 1986; 114:493-9.

74. Hjorth N, Graupe K. Azelaic acid for the treatment of acne. A clinical comparison with oral tetracycline. Acta Derm Venereol Suppl 1989;143:45-8.

75. Spellman MC, Pincus SH. Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne. Clin Ther 1998;20:711-21.

76. Graupe K, Zaumseil RP. Skinoren - a new local therapeutic agent for the treatment of acne vulgaris. In: Jahrbuch de Dermatologie. Macher E, Kolde G, Bröcker EB eds. Zülpich: Biermann, 1991:159-69.

77. Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. [Review] [53 refs]. Cutis 1996;57(Suppl.1):S20-35.

78. Holland KT, Bojar RA. The effect of azelaic acid on cutaneous bacteria. J Dermatol Treat 1989;1:17-19.

79. Breathnach AS. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid and other therapies. Cutis 1996;57(Suppl. 1):36-45.

80. Eady EA, Ingham E, Walters CE, Cove JH, Cunliffe WJ. Modulation of comedonal levels of interleukin-1 in acne patients treated with tetracyclines. J Invest Dermatol 1993;101:86-91.

81. Garner SE, Eady EA, Popescu C, Newton J, Li Wan PA. Minocycline for acne vulgaris: efficacy and safety. In: Cochrane Collaboration. Cochrane Library. Issue 2. Oxford: Update Software, 2000.

82. Plewig G, Petrozzi JW, Berendes U. Double-blind study of doxycycline in acne vulgaris. Arch Dermatol 1970;101: 435-8.

83. Hersle K, Gisslen H. Minocycline in acne vulgaris: a doubleblind study. Curr Ther Res Clin Exp 1976; 19: 339-42.

84. Crounse RG. The response of acne to placebos and antibiotics. JAMA 1965;193:906-10.

85. Lane P, Williamson DM. Treatment of acne vulgaris with tetracycline hydrochloride: a double-blind trial with 51 patients. BMJ 1969;2:76-9.

86. Wong RC, Kang S, Heezen JL. Oral ibuprofen and tetracycline for the treatment of acne vulgaris. J Am Acad Dermatol 1984;11:1076-81.

87. Anderson RL, Cook CH, Smith DE. The effect of oral and topical tetracycline on acne severity and on surface lipid composition. J Invest Dermatol 1976;66: 172-7.

88. Blaney DJ, Cook CH. Topical use of tetracycline in the treatment of acne: a double-blind study comparing topical and oral tetracycline therapy and placebo. Arch Dermatol 1976;112:971-3.

89. Smith JG, Jr., Chalker DK, Wehr RF. The effectiveness of topical and oral tetracycline for acne. Southern Med J 1976;69:695-7.

90. Braathen LR. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris. Scand J Infect Dis 1984: 16(Suppl. 43):71-5.

91. Gratton D, Raymond GP, Guertin-Larochelle S et al. Topical clindamycin versus systemic tetracycline in the treatment of acne. Results of a multiclinic trial. J Am Acad Dermatol 1982;7:50-3.

92. Feucht CL, Allen BS, Chalker DK, Smith JG, Jr. Topical erythromycin with zinc in acne. A double-blind controlled study. J Am Acad Dermatol 1980;3:483-91.

93. Stewart WD, Maddin SW, Nelson AJ et al. Therapeutic agents in acne vulgaris: I Tetracycline. Can Med Assoc J 1963;89:1096-7.

94. Ashurst PJ. Tetracycline in acne vulgaris. Practitioner 1968;200:539-41.

95. Plewig G. Vitamin A acid. Topical treatment in acne vulgaris. Pennsylvania Med 1969;72:33-5.

96. Al Mishari MA. Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris. Clin Ther 1987;9:273-80.

97. Bleeker J. Tolerance and efficacy of erythromycin stearate tablets versus enteric-coated erythromycin base capsules in the treatment of patients with acne vulgaris. J Int Med Res 1983;11:38-41.

98. Brandt H, Attila P, Ahokas T etal. Erythromycin acistrate -an alternative oral treatment for acne. J Dermatol Treat 1994;5:3-5.

99. Cullen SI, Cohan RH. Minocycline therapy in acne vulgaris. Cutis 1976;17:1208-10.

100. Gammon WR, Meyer C, Lantis S, Shenefelt P, Reizner G, Cripps DJ. Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study. J Am Acad Dermatol 1986; 14 (2Pt 1):183-6.

101. Gibson JR, Darley CR, Harvey SG, Barth J. Oral trimethoprim versus oxytetracycline in the treatment of inflammatory acne vulgaris. Br J Dermatol 1982;107: 221-4.

102. Hubbell CG, Hobbs ER, Rist T, White JW, Jr. Efficacy of minocycline compared with tetracycline in treatment of acne vulgaris. Arch Dermatol 1982;118:989-92.

103. Olafsson JH, Gudgeirsson J, Eggertsdottir GE, Kristjansson F. Doxycycline versus minocycline in the treatment of acne vulgaris: A double-blind study. J Dermatol Treat 1989;1:15-17.

104. Samuelson JS. An accurate photographic method for grading acne: initial use in a double-blind clinical comparison of minocycline and tetracycline. J Am Acad Dermatol 1985;12:461-7.

105. Blechschmidt J, Engst R, Hoting E et al. Behandlung der acne papulopustulosa-vergleich der wirksmkeit und vertraglichkeit von minocyclin und oxytetracyclin. Munchener Medizinische Wochenschrift 1987;129:562-4.

106. Cunliffe WJ, Grosshans E, Belaich S, Meynadier J, Alirezai M, Thomas L. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris. Eur J Dermatol 1998;8:161-6.

107. Fallica L, Vignini M, Rodeghiero R et al. La minociclina e la tetracicline chloridrato nel trattamento del'acne vogare. Dermatol Clin 1985;5:145-50.

108. Khanna N. Treatment of acne vulgaris with oral tetracyclines. Indian J Dermatol Venereol Leprol 1993;59:74-6.

109. Laux B. Treatment of acne vulgaris. A comparison of doxycycline versus minocycline. [German]. Hautarzt 1989;40:577-81.

110. Lorette G, Belaich S, Beylot MC, Ortonne JP. Doxycycline (Tolexine(TM)) 50 mg/day versus minocycline 100 mg/day in the treatment of acne vulgaris. Evaluation on four months of treatment. [French]. Nouv Dermatol 1994: 13:662-5.

111. Ruping KW, Tronnier H. Acne therapy: results of a multicentre study with minocycline. Royal Society of Medicine Services International Congress and Symposium Series 1985;103-8.

112. Schollhammer M, Alirezai M. Etude comparative de la lymecycline, de la minocycline et de la doxycycline dans la traitement de l'acne vulgaire. Real Ther Derm Venerol 1994;42:24-6.

113. Waskiewicz W, Grosshans E. Traitement de l'acne juvenile par les cyclines de deuxieme generation. Nouv Dermatol 1982;11:8-11.

114. Christian GL, Krueger GG. Clindamycin v placebo as adjunctive therapy in moderately severe acne. Arch Dermatol 1975;111:997-1000.

115. Lucchina LC, Kollias N, Gillies R et al. Fluorescence photography in the evaluation of acne. J Am Acad Dermatol 1996;35:58-63.

116. Thomsen RJ, Stranieri A, Knutson D, Strauss JS. Topical clindamycin treatment of acne. Clinical, surface lipid composition, and quantitative surface microbiology response. Arch Dermatol 1980; 116: 1031-4.

117. Becker LE, Bergstresser PR, Whiting DA et al. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study. Arch Dermatol 1981;117:482-5.

118. Guin JD. Treatment of acne vulgaris with topical clindamycin phosphate: a double-blind study. Int J Dermatol 1981;20:286-8.

119. Kuhlman DS, Callen JP. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris. Cutis 1986;38:203-6.

Petersen MJ, Krusinski PA, Krueger GG. Evaluation of

1% clindamycin phosphate lotion in the treatment of acne. Curr Ther Res 1986;40:232-8.

Ellis CN, Gammon WR, Stone DZ, Heezen-Wehner JL.

A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris. Cutis

1988;42:245-7.

McKenzie MW, Beck DC, Popovich NG. Topical clindamycin formulations for the treatment of acne vulgaris. An evaluation. Arch Dermatol 1981; 117: 630-4.

Jones EL, Crumley AF. Topical erythromycin v blank vehicle in a multiclinic acne study. Arch Dermatol 1981;117:551-3.

Hellgren L, Vincent J. Entzundungshemmung bei akne vulgaris durich ein erythromycin-externum in alkoholischer losung. Dermatol Monatsschr 1983; 169:705.

Lesher Jr JL, Chalker DK, Smith Jr JG. An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris. J Am Acad Dermatol 1985;12:526-31.

LLorca M, Hernandez-Gill A, Ramos M et al.

Erythromycin laurilsulfate in the topical treatment of acne vulgaris. Curr Ther Res 1982;32:14-20.

Perez M, Aspiolea F, De Moragas JM. [Comparative double-blind study of topical clindamycin phosphate and oral tetracycline in the treatment of acne]. [Spanish].

Med Cutan Ibero Lat Am 1987;15:173-7.

Pochi PE, Bagatell FK, Ellis CN et al. Erythromycin 2

percent gel in the treatment of acne vulgaris. Cutis

1988;41:132-6.

Prince RA, Busch DA, Hepler CD, Feldick HG. Clinical trial of topical erythromycin in inflammatory acne. Drug Intell Clin Pharm 1981;15:372-6. Chalker DK, Shalita A, Smith JG, Jr, Swann RW. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983;9:933-6.

Schachner L, Pestana A, Kittles C. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation. [see comments.]. J Am Acad Dermatol 1990;22:489-95.

Strauss JS, Stranieri AM. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol 1984;11:86-9.

133. Hansted B, Jorgensen J, Reymann F, Christiansen J. Fucidin(TM) cream for topical treatment of acne vulgaris. Curr Ther Res Clin Exp 1985;37:249-53.

134. Sommer S, Bojar R, Cunliffe WJ, Holland D, Holland KT, Naags H. Investigation of the mechanism of action of 2% fusidic acid lotion in the treatment of acne vulgaris. Clin Exp Dermatol 1997;22:211-15.

135. Knutson DD, Swinyer LJ, Smoot WH. Meclocycline sulfosalicylate. Topical antibiotic agent for the treatment of acne vulgaris. Cutis 1981;27:203-4.

136. Tong D, Peters W, Barnetson RSC. Evaluation of 0-75% metronidazole gel in acne - a double-blind study. Clin Exp Dermatol 1994;19:221-3.

137. Franz E, Weidner-Strahl S. The effectiveness of topical antibacterials in acne: a double-blind clinical study. J Int Med Res 1978;6:72-7.

138. Parker F. A comparison of clindamycin 1% solution versus clindamycin 1% gel in the treatment of acne vulgaris. Int J Dermatol 1987;26:121-2.

139. Goltz RW, Coryell GM, Schnieders JR, Neidert GL. A comparison of Cleocin T 1 percent solution and Cleocin T 1 percent lotion in the treatment of acne vulgaris. Cutis 1985;36:265-8.

140. Henderson TA, Olson WH, Leach AD. A single-blind, randomized comparison of erythromycin pledgets and clindamycin lotion in the treatment of mild-to-moderate facial acne vulgaris. Adv Ther 1995;12: 172-7.

141. Leyden JJ, Shalita AR, Saatjian GD, Sefton J. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris. J Am Acad Dermatol 1987;16:822-7.

142. Mills OH, Berger RS, Kligman AM, McElroy JA, Di Matteo J. A comparative study of Erycette(TM) v Cleocin-T(TM). Adv Ther 1992;9:14-20.

143. Thomas DR, Raimer S, Smith EB. Comparison of topical erythromycin 1-5 percent solution versus topical clindamycin phosphate 1-0 percent solution in the treatment of acne vulgaris. Cutis 1982;29:624-5.

144. Padilla RS, McCabe JM, Becker LE. Topical tetracycline hydrochloride v. topical clindamycin phosphate in the treatment of acne: a comparative study. Int J Dermatol 1981;20:445-8.

145. Robledo AA, Lopez BE, del Pino GJ et al. Multicentric comparative study of the efficacy and tolerance of clindamycin phosphate 1% topical solution and tetracycline topical solution for the treatment of acne vulgaris. Curr Ther Res Clin Exp 1988;43:21-6.

146. Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol 1995;34:434-7.

147. Borglund E, Hagermark O, Nord CE. Impact of topical clindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris. Scand J Infect Dis 1984;16(Suppl. 43):76-81.

148. Stoughton RB, Cornell RC, Gange RW, Walter JF. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris. Cutis 1980;26:424-5.

149. Katsambas A, Towarky AA, Stratigos J. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris. Br J Dermatol 1987;116:387-91.

150. Cornbleet HA. Long-term therapy of acne with tetracycline. Arch Dermatol 1961;83:414-16.

151. Hjorth N, Schmidt H, Thomsen K, Dela K. Meclosorb((TM)), a new topical antibiotic agent in the treatment of acne vulgaris: A double-blind clinical study. Acta Derm Venereol 1984;64:354-7.

152. Rapaport M, Puhvel SM, Reisner RM. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris. Cutis 1982;30:122-6.

153. Drake LA. Comparative efficacy and tolerance of Cleocin T topical gel (clindamycin phosphate topical gel) versus oral minocycline in the treatment of acne vulgaris. 1980 unpublished data (Pharmacia and Upjohn Ltd).

154. Peacock CE, Price C, Ryan BE, Mitchell AD. Topical clindamycin (Dalacin T(TM)) compared to oral minocycline (Minocin 50(TM)) in treatment of acne vulgaris. A randomized observer-blind controlled trial in three university student health centres. Clin Trials J 1990;27:219-28.

155. Sheehan-Dare RA, Papworth-Smith J, Cunliffe WJ. A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris. Acta Derm Venereol 1990;70:534-7.

156. Wethered R. Sodium fusidate in acne. Practitioner 1964;193:802-4.

157. Darrah AJ, Gray PL. An open multicentre study to compare fusidic acid lotion and oral minocycline in the treatment of mild-to-moderate acne vulgaris of the face. Eur J Clin Res 1996;8:97-107.

158. Norris JFB, Hughes BR, Basey AJ, Cunliffe WJ. A comparison of the effectiveness of topical tetracycline, benzoyl-peroxide gel and oral oxytetracycline in the treatment of acne. Clin Exp Dermatol 1991;16:31-3.

159. Stainforth J, Macdonald-Hull S, Papworth-Smith JW et al. A single-blind comparison of topical erythromycin/zinc lotion and oral minocycline in the treatment of acne vulgaris. J Dermatol Treat 1993;4:119-22.

160. Gollnick H. A new therapeutic agent: Azelaic acid in acne treatment. J Dermatol Treat 1990;1(Suppl. 3):S23-S28.

161. Tucker SB, Tausend R, Cochran R, Flannigan SA. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br J Dermatol 1984;110:487-92.

162. Swinyer LJS, Baker MD, Swinyer TA, Mills OH, Jr. A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris. Br J Dermatol 1988;119:615-22.

163. Burke B, Eady EA, Cunliffe WJ. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol 1983;108:199-204.

164. Borglund E, Kristensen B, Larsson-Stymne B, Strand A, Veien NK, Jakobsen HB. Topical meclocycline sulfosalicylate, benzoyl peroxide, and a combination of the two in the treatment of acne vulgaris. Acta Derm Venereol 1991;71:175-8.

165. Gamborg NP. Topical metronidazole gel. Use in acne vulgaris. Int J Dermatol 1991;30:662-6.

166. Cambazard F. Clinical efficacy of Velac(TM), a new tretinoin and clindamycin phosphate gel in acne vulgaris. J Eur Acad Dermatol Venereol 1998;11(Suppl. 1):S20-S27.

167. Zouboulis C, Derumeaux L, Decroix J, Maciejewska-Udziela B, Cambazard F, Stuhlert A. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac(TM)) applied once daily and a clindamycin lotion formulation (Dalacin T(TM)) applied twice daily in the topical treatment of acne vulgaris. Br J Dermatol 2000;143:498-505.

Rietschel RL, Duncan SH. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 1983;22:41-3.

Richter JR, Bousema MT, De Boulle KLV, Degreef HJ, Poli F. Efficacy of a fixed clindamycin phosphate 1-2%, tretinoin 0-025% gel formulation (Velac) in the topical control of facial acne lesions. J Dermatol Treat 1998;9:81-90. Mills OH, Jr., Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol 1978;58:555-7.

Packman AM, Brown RH, Dunlap FE, Kraus SJ, Webster GF. Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion. Int J Dermatol 1996;35:209-11.

Chu A, Huber FJ, Plott RT. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1-2% solution in the treatment of acne vulgaris. Br J Dermatol 1997;136:235-8. Sklar JL, Jacobson C, Rizer R, Gans EH . Evaluation of Triaz 10% Gel and Benzamycin in acne vulgaris. J Dermatol Treat 1996;7:147-52. Marsden J. Evidence that the method of use, dose and duration of treatment with benzoyl peroxide and tetracycline determines response of acne. J R Soc Med 1985;78(Suppl. 10):25-8.

Brooks JS. The use of acmed in acne. Australasian J Dermatol 1968;9:256-7.

Noble W, Naidoo J. Evolution of antibiotic resistance in Staphylococcus aureus: the role of the skin. Br J Dermatol 1978;98:481-9.

Eady EA, Holland KT, Cunliffe WJ. Should topical antibiotics be used for the treatment of acne vulgaris?. [Review] [99 refs]. Br J Dermatol 1982;107:235-46. Editorial. Antimicrobial resistance. BMJ 1998;317:609-10. Cooper A. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aus 1998;169:259-61.

Eady EA, Cove JH, Blake J, Holland KT, Cunliffe WJ. Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988: 118:415-23.

181. Hughes BR, Murphy CE, Barnett J, Cunliffe WJ. Strategy of acne therapy with long-term antibiotics. Br J Dermatol 1989;121:623-8.

182. Greenwood R, Burke B, Cunliffe WJ. Evaluation of a therapeutic strategy for the treatment of acne vulgaris with conventional therapy. Br J Dermatol 1986;114:353-8.

183. Mandy S. Chest and back acne: a retrospective review. Adv Ther 1995;12:321-32.

184. Layton AM, Hughes BR, Macdonald-Hull S et al. Seborrhoea - an indicator for poor clinical response in acne patients treated with antibiotics. Clin Exp Dermatol 1992;17:173-5.

185. Leyden JJ, Marples RR, Mills OH, Jr, Kligman AM. Gramnegative folliculitis: a complication of antibiotic therapy in acne vulgaris. Br J Dermatol 1973;88:533-8.

186. Chopra I, Hawkey P, Hinton M. Tetracyclines: molecular and clinical aspects. J Antimicrob Chemother 1992;29: 245-77.

187. Meyer FP. Minocycline for acne. Food reduces minocycline's availability. BMJ 1996;312:1101.

188. Lleyden JJ. Absorption of minocycline hydrochloride and tetracycline hydrochloride: effect of food, milk and iron. J Am Acad Dermatol 1985;12:308-12.

189. Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994;131:331-6.

190. Becker FT. The acne problem. Arch Dermatol Syphiol 1953;67:173.

191. Robinson H. Role of antibiotics in therapy of acne. Arch Dermatol Syphiol 1954;69:414-17.

192. Smith E, Mortimer PS. Tetracycline in acne vulgaris. Br J Dermatol 1967;79:78-84.

193. Aulzberger M, Witten V, Steagall R. Treatment of acne vulgaris. JAMA 1960;173:1911-15.

194. Plewig G, Kligman AM. Acne: Morphogenesis and Treatment, 1st ed. Berlin: Springer-Verlag, 1975.

195. Dreno B, Bodokh I, Chivot M et al. [ECLA grading: a system of acne classification for every day dermatological practice]. [French]. Ann Dermatol Venereol 1999; 126:136-41.

196. Gardner KJ, Eady EA, Cove JH, Taylor JP, Cunliffe WJ. Comparison of serum antibiotic levels in acne patients receiving the standard or a modified release formulation of minocycline hydrochloride. Clin Exp Dermatol 1997;22:72-6.

197. Akamatsu H, Nishijima S, Akamatsu M, Kurokawa I, Asada Y. Clinical evaluation of roxithromycin in patients with acne. J Int Med Res 1996;24:109-14.

198. Baer RL, Leshaw SM, Shalita AR. High-dose tetracycline therapy in severe acne. Arch Dermatol 1976; 112: 479-81.

199. Friedman-Kien A, Shalita AR, Baer RL. Tetracycline therapy in acne vulgaris. Arch Dermatol 1972;105:608.

200. Burke BM, Cunliffe WJ. The assessment of acne vulgaris -the Leeds technique. Br J Dermatol 1984;111:83-92.

201. Goolamali S. Management of acne vulgaris. Prescribers J 1990;30:78-84.

202. Fyrand O, Jakobsen HB. Water-based versus alcohol-based benzoyl peroxide preparations in the treatment of acne vulgaris. Dermatologica 1986;172: 263-7.

203. Milikan LE, Ameln R. Use of Buf-Puf and benzoyl peroxide in the treatment of acne. Cutis 1981;28:201-5.

Was this article helpful?

0 0
How To Cure Acne

How To Cure Acne

This information has helped thousands of people understand their acne, and subsequently make it disappear! If you are in need of comprehensive information on every aspect of acne, there is no better resource.

Get My Free Ebook


Post a comment